Amy G. Feldman

ORCID: 0000-0003-4021-5615
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pediatric Hepatobiliary Diseases and Treatments
  • Congenital Anomalies and Fetal Surgery
  • Liver Disease and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Vaccine Coverage and Hesitancy
  • Gallbladder and Bile Duct Disorders
  • Hepatitis Viruses Studies and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • Renal Transplantation Outcomes and Treatments
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • Metabolism and Genetic Disorders
  • Transplantation: Methods and Outcomes
  • Adolescent and Pediatric Healthcare
  • Respiratory viral infections research
  • Hematopoietic Stem Cell Transplantation
  • Animal Virus Infections Studies
  • Mobile Health and mHealth Applications
  • Neonatal Health and Biochemistry
  • COVID-19 Clinical Research Studies
  • Drug Transport and Resistance Mechanisms
  • COVID-19 Impact on Reproduction
  • Liver Diseases and Immunity
  • Childhood Cancer Survivors' Quality of Life

University of Colorado Denver
2015-2025

Children's Hospital Colorado
2015-2025

University of Colorado Anschutz Medical Campus
2024-2025

E Ink (South Korea)
2022

Outcomes Research Consortium
2017-2022

Lurie Children's Hospital
2013

Northwestern University
2013

Boston Children's Hospital
2013

Inova Fairfax Hospital
1993

Care Resource
1993

Benjamin L. Shneider John C. Magee Saul J. Karpen Elizabeth B. Rand Michael R. Narkewicz and 95 more Lee M. Bass Kathleen B. Schwarz Peter F. Whitington Jorge A. Bezerra Nanda Kerkar Barbara Haber Philip Rosenthal Yumirle P. Turmelle Jean P. Molleston Karen F. Murray Vicky L. Ng Kasper S. Wang René Romero Robert H. Squires Ronen Arnon Averell H. Sherker Jeffrey Moore Wen Ye Ronald J. Sokol Estella M. Alonso Elizabeth Kaurs Sue Kelly Kevin E. Bove James E. Heubi Alexander Miethke Greg Tiao J. Kenneth Denlinger Andrea Ferris Amy G. Feldman Cara L. Mack Frederick J. Suchy Shikha S. Sundaram Johan Van Hove Michelle Hite S KANTOR Todd Q. Miller J. Joshua Smith Becky VanWinkle Kathleen M. Loomes Henry C. Lin David A. Piccoli Pierre Russo Nancy B. Spinner Lindsay C. Brown Emily Elgert Jessi Erlichman Feras Alissa Douglas Lindblad George Mazariegos Roberto Ortiz‐Aguayo David H. Perlmutter Rakesh Sindhi Veena Venkat Jerry Vockley Kathy Bukauskas Adam Kufen Madeline Schulte Laura N. Bull Shannon Fleck Camille Langlois Jeffrey Teckman Vikki Kociela Stacy Postma Kathleen Mullan Harris Molly Bozic Girish Subbarao Beth Byam Ann Klipsch Cindy Sawyers Simon Horslen Evelyn Hsu Kara Cooper Melissa Young Binita M. Kamath Maria DeAngelis Constance M. O’Connor Krista VanRoestel Arpita Parmar Claudia Quammie Kelsey Hung Stephen L. Guthery Kyle Jensen Ann Rutherford Nanda Kerker Sonia Michail Danny Thomas Catherine J. Goodhue Nikita Gupta Mariam Vos Liezl de la Cruz-Tracey Dana Hankerson-Dyson Rita Tory Taieshia C. Turner-Green Allison Wellons Mary L. Brandt

10.1016/j.jpeds.2015.11.058 article EN The Journal of Pediatrics 2015-12-24

Cholestatic jaundice is a common presenting feature of neonatal hepatobiliary and metabolic dysfunction. Any infant who remains jaundiced beyond age 2 to 3 weeks should have the serum bilirubin level fractionated into conjugated (direct) unconjugated (indirect) portion. Conjugated hyperbilirubinemia never physiologic or normal. The differential diagnosis cholestasis extensive, step-wise approach based on initial history physical examination useful rapidly identify underlying etiology. Early...

10.1542/neo.14-2-e63 article EN NeoReviews 2013-02-01

Pediatric transplant recipients are at risk for vaccine-preventable infections owing to immunosuppression, suboptimal response vaccines before and after transplant, potential underimmunization if occurred early in life. However, the incidence burden of illness from this population is unknown.To evaluate pediatric solid organ number hospitalizations first 5 years determine associated morbidity, mortality, costs.A retrospective cohort study January 1, 2004, December 31, 2011, with follow-up...

10.1001/jamapediatrics.2018.4954 article EN JAMA Pediatrics 2019-01-14

Abstract Nationally, immunization delivery has decreased significantly during the coronavirus disease 2019 (COVID-19) pandemic. Internationally, >60 national vaccine programs have been disrupted or suspended. As a result of these declines, global community is at risk for resurgence in vaccine-preventable infections including measles, pertussis, and polio—all highly contagious diseases that significant morbidity mortality children. Measles outbreaks already occurred many countries...

10.1093/cid/ciab127 article EN other-oa Clinical Infectious Diseases 2021-02-09

Importance Live vaccines (measles-mumps-rubella [MMR] and varicella-zoster virus [VZV]) have not been recommended after solid organ transplant due to concern for inciting vaccine strain infection in an immunocompromised host. However, the rates of measles, mumps, varicella are rising nationally internationally, leaving susceptible children at risk life-threating conditions. Objective To determine safety immunogenicity live pediatric liver kidney recipients. Design, Setting, Participants This...

10.1001/jamanetworkopen.2023.37602 article EN cc-by-nc-nd JAMA Network Open 2023-10-12

ABSTRACT Background Despite the existence of institutional protocols, liver transplant centers often have variability in early immunosuppression practices. We aimed to measure within‐center after pediatric (LT) and examine its association with one‐year outcomes. Methods analyzed LTs from 2013 2018 United Network for Organ Sharing registry, data aggregated by center. categorized induction regimen as corticosteroids only vs. T‐cell depleting antibody non‐T‐cell antibody. Primary exposures were...

10.1111/petr.70018 article EN cc-by Pediatric Transplantation 2025-01-08

ABSTRACT Introduction Biliary atresia (BA) is the most common indication for liver transplantation (LT) in children. We aimed to identify risk factors associated with survival young patients BA modern era. Methods performed a retrospective analysis of aged < 2 years who received their first isolated LT available data from United Network Organ Sharing database (01/2013–12/2022). Factors included multivariable Cox regression were graft type, race/ethnicity, insurance status, laboratory...

10.1111/petr.70031 article EN Pediatric Transplantation 2025-01-21

ABSTRACT Background Biliary strictures (BS) remain a challenge in pediatric liver transplant (LT). Achievement of the “Optimal Outcome” (OBO), stricture resolution without recurrence or surgery is goal. We analyzed cost associated with different management. Methods Society Pediatric LT (SPLIT) data were matched Health Information System (PHIS) by dates birth and transplant, center sex. SPLIT used to identify recipients (2011–2016) BS. Procedure admissions costs from PHIS inflation‐adjusted...

10.1111/petr.70009 article EN Pediatric Transplantation 2025-03-22

A leading theory regarding the pathogenesis of biliary atresia (BA) is that bile duct injury initiated by a virus infection, followed an autoimmune response targeting ducts. In experimental models diseases, B cells have been shown to play important role. The aim this study was determine role in development obstruction Rhesus rotavirus (RRV)-induced mouse model BA. Wild-type (WT) and cell-deficient (Ig-α(-/-)) mice received RRV shortly after birth. Ig-α(-/-) RRV-infected had significantly...

10.1371/journal.pone.0073644 article EN cc-by PLoS ONE 2013-08-21
Coming Soon ...